MYGN
Myriad Genetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$3.19
−1.24%Leverage
- Debt / equity
- 0.69x
- Net debt / equity
- 0.31x
- Debt / assets
- 0.33x
- Debt / EBITDA
- -4.66x
- Net debt / EBITDA
- -2.11x
Liquidity & coverage
- Current ratio
- 2.21x
- Quick ratio
- 1.98x
- Cash ratio
- 0.88x
- Interest coverage
- -6.01x
- EBITDA / interest
- -2.76x
- Working capital
- $158.3M
Cash & dividend
- FCF / debt
- -0.04x
- Cash flow / debt
- 0.04x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026